tiprankstipranks
Outlook Therapeutics (OTLK)
NASDAQ:OTLK

Outlook Therapeutics (OTLK) Similar Stocks

Compare
1,362 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Outlook Therapeutics
$1.64
$54.75M
-80.38%
2 Buy
1 Hold
0 Sell
Moderate Buy
Neurocrine
$116.11
$11.36B
34.72
-12.94%
17 Buy
5 Hold
0 Sell
Strong Buy
EyePoint Pharmaceuticals
$6.35
$433.39M
-76.15%
7 Buy
0 Hold
0 Sell
Strong Buy
Ocular Therapeutix
$7.25
$1.14B
-25.26%
8 Buy
0 Hold
0 Sell
Strong Buy
Kala Pharmaceuticals
$6.84
$41.66M
-14.50%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
OTLK
Outlook Therapeutics
1.64
-6.94
-80.89%
NBIX
Neurocrine
116.11
-17.26
-12.94%
EYPT
EyePoint Pharmaceuticals
6.35
-19.75
-75.67%
OCUL
Ocular Therapeutix
7.25
-2.45
-25.26%
KALA
Kala Pharmaceuticals
6.84
-1.16
-14.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis